662 Shares in HCA Healthcare, Inc. (NYSE:HCA) Acquired by YHB Investment Advisors Inc.

YHB Investment Advisors Inc. bought a new position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 662 shares of the company's stock, valued at approximately $229,000.

Other institutional investors have also recently added to or reduced their stakes in the company. Sanders Capital LLC increased its position in HCA Healthcare by 1.0% during the 4th quarter. Sanders Capital LLC now owns 11,655,563 shares of the company's stock worth $3,498,417,000 after purchasing an additional 116,826 shares in the last quarter. First Eagle Investment Management LLC increased its position in shares of HCA Healthcare by 0.5% in the fourth quarter. First Eagle Investment Management LLC now owns 4,503,849 shares of the company's stock worth $1,351,830,000 after acquiring an additional 23,177 shares in the last quarter. Geode Capital Management LLC lifted its holdings in shares of HCA Healthcare by 1.3% during the 4th quarter. Geode Capital Management LLC now owns 3,871,057 shares of the company's stock valued at $1,159,882,000 after acquiring an additional 50,321 shares in the last quarter. Capital World Investors increased its holdings in HCA Healthcare by 0.7% in the 4th quarter. Capital World Investors now owns 2,928,452 shares of the company's stock valued at $878,975,000 after purchasing an additional 19,121 shares in the last quarter. Finally, Norges Bank acquired a new position in shares of HCA Healthcare during the fourth quarter worth about $840,286,000. Hedge funds and other institutional investors own 62.73% of the company's stock.

Insider Buying and Selling

In other news, COO Jon M. Foster sold 15,698 shares of the business's stock in a transaction on Tuesday, May 13th. The stock was sold at an average price of $369.32, for a total value of $5,797,585.36. Following the sale, the chief operating officer now owns 12,646 shares of the company's stock, valued at approximately $4,670,420.72. The trade was a 55.38% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 1.30% of the company's stock.

HCA Healthcare Stock Up 0.1%

NYSE:HCA opened at $379.06 on Wednesday. HCA Healthcare, Inc. has a 52 week low of $289.98 and a 52 week high of $417.14. The firm has a market capitalization of $91.19 billion, a PE ratio of 16.85, a price-to-earnings-growth ratio of 1.31 and a beta of 1.49. The company has a current ratio of 1.19, a quick ratio of 1.06 and a debt-to-equity ratio of 69.07. The stock has a 50 day moving average of $363.94 and a 200-day moving average of $335.66.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings results on Friday, April 25th. The company reported $6.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.75 by $0.70. The company had revenue of $18.32 billion during the quarter, compared to the consensus estimate of $18.26 billion. HCA Healthcare had a net margin of 8.07% and a return on equity of 1,063.91%. The company's revenue for the quarter was up 5.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $5.36 earnings per share. Analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, June 30th. Stockholders of record on Monday, June 16th will be issued a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.76%. The ex-dividend date is Monday, June 16th. HCA Healthcare's dividend payout ratio (DPR) is 12.81%.

Analyst Ratings Changes

HCA has been the topic of several recent research reports. Wall Street Zen raised HCA Healthcare from a "hold" rating to a "buy" rating in a research report on Monday, April 28th. Stephens upgraded shares of HCA Healthcare to a "strong-buy" rating in a research note on Monday, June 2nd. Royal Bank Of Canada upped their price objective on shares of HCA Healthcare from $376.00 to $404.00 and gave the company an "outperform" rating in a research report on Monday. Guggenheim initiated coverage on HCA Healthcare in a research report on Wednesday, April 9th. They set a "neutral" rating on the stock. Finally, Robert W. Baird restated a "neutral" rating and set a $336.00 price objective (down previously from $396.00) on shares of HCA Healthcare in a research note on Tuesday, April 15th. Seven research analysts have rated the stock with a hold rating, twelve have issued a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, HCA Healthcare presently has a consensus rating of "Moderate Buy" and an average target price of $394.33.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.